s6y

Oxford Immunotec Global PLC

CIK
1586049
Industry
In Vitro & In Vivo Diagnostic Substances

Financials 29

  1. 10-Q Quarterly Report for period ending Sep 30, 2020
  2. 10-Q Quarterly Report for period ending Jun 30, 2020
  3. 10-Q Quarterly Report for period ending Mar 31, 2020
  4. 10-K Annual Report for period ending Dec 31, 2019
  5. 10-Q Quarterly Report for period ending Sep 30, 2019
  6. 10-Q Quarterly Report for period ending Jun 30, 2019
  7. 10-Q Quarterly Report for period ending Mar 31, 2019
  8. 10-K Annual Report for period ending Dec 31, 2018
  9. NT 10-K Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10-KT for period ending Dec 31, 2018
  10. 10-Q Quarterly Report for period ending Sep 30, 2018

All 29 financials filings

News 93

  1. 8-K Current report filing
  2. 8-K/A Current report filing
  3. 8-K Current report filing
  4. 8-K Current report filing
  5. 8-K Current report filing
  6. 8-K Current report filing
  7. 8-K Current report filing
  8. 8-K Current report filing
  9. 8-K Current report filing
  10. 8-K Current report filing

All 93 news filings

Ownership 263

  1. SC 13G/A Major Shareholders
  2. SC 13G/A Major Shareholders
  3. SC 13G Major Shareholders
  4. 4 Statement of changes in beneficial ownership of securities
  5. 4 Statement of changes in beneficial ownership of securities
  6. 4 Statement of changes in beneficial ownership of securities
  7. 4 Statement of changes in beneficial ownership of securities
  8. 4 Statement of changes in beneficial ownership of securities
  9. 4 Statement of changes in beneficial ownership of securities
  10. 4 Statement of changes in beneficial ownership of securities

All 263 ownership filings

Prospectus 21

  1. S-8 POS Post-effective amendment to a S-8 registration statement
  2. S-8 POS Post-effective amendment to a S-8 registration statement
  3. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  4. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  5. S-3/A Registration statement for specified transactions by certain issuers
  6. S-3 Registration statement for specified transactions by certain issuers
  7. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  8. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  9. S-3 Registration statement for specified transactions by certain issuers
  10. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

All 21 prospectus filings

Proxies 16

  1. DEFM14A Definitive proxy statement relating to a merger, acquisition, or disposition
  2. PREM14A Preliminary proxy statement relating to a merger, acquisition, or disposition
  3. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  4. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  5. DEF 14A Definitive proxy statements
  6. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  7. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  8. DEF 14A Definitive proxy statements
  9. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  10. DEF 14A Definitive proxy statements

All 16 proxies filings

Other 40

  1. 15-12B Notice of termination of registration of a class of securities under Section 12(b)
  2. 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
  3. CT ORDER Order Granting Confidential Treatment
  4. CT ORDER Order Granting Confidential Treatment
  5. CT ORDER Order Granting Confidential Treatment
  6. SEC STAFF LETTER
  7. SEC STAFF LETTER
  8. CT ORDER Order Granting Confidential Treatment
  9. CT ORDER Order Granting Confidential Treatment
  10. CT ORDER Order Granting Confidential Treatment

All 40 other filings